Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer

episode

Breast Cancer Update not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Ireland collapse in Kosovo as Israel game looms 13 min · 25 Sep 2026 · Today with David McCullagh

The Week: Trump vs the Press, Meta’s AI Win, and the Turning Political Tide 22 min · 25 Sep 2026 · The Prof G Pod with Scott Galloway

Armchair Anonymous: Bad Customer 54 min · 25 Sep 2026 · Armchair Expert with Dax Shepard

The Parts We Can't Erase 45 min · 25 Sep 2026 · Untraditionally Lala

Headlines: Car crash kills junior police officer 4 min · 25 Sep 2026 · The Daily Aus

Day 268: Rebuilding the Temple (2026) 29 min · 25 Sep 2026 · The Bible in a Year (with Fr. Mike Schmitz)

Report any issue

Source

Recorded25 Oct 2024

Publisherfeeds.captivate.fm ↗

Handlerec:5010170

Show notes

Dr Erika Hamilton from Sarah Cannon Research Institute in Nashville discusses emerging evidence with proteolysis-targeting chimera estrogen receptor degraders for HR-positive metastatic breast cancer.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related